Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2026-06-02 16:30:06 ET · period of report 2026-06-01 · accession 0001193125-26-253603 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-02 16:30 | 2026-06-01 | SNDX | Goldan Keith A. | CFO | S - Sale | $18.99 | -1,177 | 139.3K | -0.8% | -$22.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-01 | S | D | 1,177 | $18.99 | 139,252 | D | — | — | (F1) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. |